Evidence map›Paper›PMID 41847112›Full record

ArticleiScience2026

Enrichment of HLA-DR

Kajetana Bevc, Shipin Zhang, Andres Pazos, Ivan Berest, Marina Fonti, Gian Salzmann, Valentino Bruhin, Jakob Hax, Ana Alonso Perez, Rodolfo Gomez and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kajetana BevcTissue Engineering + Biofabrication Laboratory, Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland.
Shipin ZhangTissue Engineering + Biofabrication Laboratory, Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland.
Andres PazosHealth Research Institute of Santiago de Compostela, Santiago Clinic Hospital, Santiago de Compostela, Spain.
Ivan BerestFlow Cytometry Core Facility, ETH Zürich, Zurich, Switzerland.
Marina FontiTissue Engineering + Biofabrication Laboratory, Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland.
Gian SalzmannSchulthess Klinik, Department for Knee Surgery, Zurich, Switzerland.
Valentino BruhinSchulthess Klinik, Department for Knee Surgery, Zurich, Switzerland.
Jakob HaxSchulthess Klinik, Department for Knee Surgery, Zurich, Switzerland.
Ana Alonso PerezHealth Research Institute of Santiago de Compostela, Santiago Clinic Hospital, Santiago de Compostela, Spain.
Rodolfo GomezHealth Research Institute of Santiago de Compostela, Santiago Clinic Hospital, Santiago de Compostela, Spain.
Florian MairFlow Cytometry Core Facility, ETH Zürich, Zurich, Switzerland.
Isabelle C ArnoldInstitute of Experimental Immunology, University of Zürich, Zurich, Switzerland.
Marcy Zenobi WongTissue Engineering + Biofabrication Laboratory, Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils are increasingly recognized as functionally versatile immune cells, with tissue-specific phenotypes that extend beyond their classical role in acute inflammation. In osteoarthritis (OA), neutrophils are abundant in synovial fluid (SF), which has been linked to worse symptoms. Here, we characterized neutrophils in OA IFP and identified a distinct population of HLA-DR

Indexed as

ImmunologyProteomics

Identifiers

PMID41847112
PMCPMC12990351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.